Variability in the expression of polycomb proteins in different normal and tumoral tissues. A pilot study using tissue microarrays

Modern Pathology

Volumn 19, Issue 5, 2006, Pages 684-694

  Sánchez Beato, Margarita ^a   Sánchez, Esther ^b   González Carreró, Joaquín ^c   Morente, Manuel ^a   Díez, Ana ^a   Sánchez Verde, Lydia ^a   Martín, María Carmen ^a   Cigudosa, Juan C ^a   Vidal, Miguel ^d   Piris, Miguel A ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL NUESTRA SEÑORA DEL PRADO   (Spain)

^c UNIVERSITY OF VIGO   (Spain)

^d CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

Author keywords

Cancer; FISH; Immunohistochemistry; Polycomb; Tissue microarray

Indexed keywords

CELL PROTEIN; POLYCOMB GROUP PROTEIN; PROTEIN BMI1; PROTEIN HPH1; PROTEIN MEL18; PROTEIN RING1; PROTEIN RNF2; PROTEIN RYBP; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BENIGN TUMOR; CELL TYPE; CLEAR CELL CARCINOMA; CONTROLLED STUDY; ENDOCRINE TUMOR; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROINTESTINAL TUMOR; GENE AMPLIFICATION; GENE LOCUS; GERM CELL TUMOR; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LYMPHATIC SYSTEM TUMOR; LYMPHOMA; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MANTLE CELL LYMPHOMA; OLIGODENDROGLIOMA; PARATHYROID ADENOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE MICROARRAY; TISSUE SPECIFICITY;

CARRIER PROTEINS; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; NEOPLASMS; NUCLEAR PROTEINS; PILOT PROJECTS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; TISSUE ARRAY ANALYSIS; UBIQUITIN-PROTEIN LIGASES;

EID: 33646161725     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800577     Document Type: Article

References (56)

1. Pirrotta V. Polycomb silencing and the maintenance of stable chromatin states. Results Probl Cell Differ 1999;25:205-228.
2. Mahmoudi T, Verrijzer CP. Chromatin silencing and activation by Polycomb and trithorax group proteins. Oncogene 2001;20:3055-3066.
3. Jacobs JJ, van Lohuizen M. Polycomb repression: from cellular memory to cellular proliferation and cancer. Biochim Biophys Acta 2002;1602:151-161.
4. Satijn DP, Otte AP. RING1 interacts with multiple Polycomb-group proteins and displays tumorigenic activity. Mol Cell Biol 1999;19:57-68.
5. Hashimoto N, Brock HW, Nomura M, et al. RAE28, BMI1, and M33 are members of heterogeneous multimeric mammalian Polycomb group complexes. Biochem Biophys Res Commun 1998;245:356-365.
6. Alkema MJ, Bronk M, Verhoeven E, et al. Identification of Bmi1-interacting proteins as constituents of a multimeric mammalian polycomb complex. Genes Dev 1997;11:226-240.
7. Schoorlemmer J, Marcos-Gutierrez C, Were F, et al. Ring1A is a transcriptional repressor that interacts with the Polycomb-M33 protein and is expressed at rhombomere boundaries in the mouse hindbrain. EMBO J 1997;16:5930-5942.
8. Garcia E, Marcos-Gutierrez C, Lorente MdM, et al. RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex, and with the transcription factor YY1. EMBO J 1999;18:3404-3418.
9. Wang H, Wang L, Erdjument-Bromage H, et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature 2004;431:873-878.
10. Sewalt RG, van der Vlag J, Gunster MJ, et al. Characterization of interactions between the mammalian polycomb-group proteins Enx1/EZH2 and EED suggests the existence of different mammalian polycomb-group protein complexes. Mol Cell Biol 1998;18:3586-3595.
11. Czermin B, Melfi R, McCabe D, et al. Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell 2002;111:185-196.
12. Breiling A, Turner BM, Bianchi ME, et al. General transcription factors bind promoters repressed by Polycomb group proteins. Nature 2001;412:651-655.
13. Trimarchi JM, Fairchild B, Wen J, et al. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc Natl Acad Sci USA 2001;98:1519-1524.
14. van der Vlag J, Otte AP. Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat Genet 1999;23:474-478.
15. van Lohuizen M. Functional analysis of mouse Polycomb group genes. Cell Mol Life Sci 1998;54:71-79.
16. Lessard J, Baban S, Sauvageau G. Stage-specific expression of polycomb group genes in human bone marrow cells. Blood 1998;91:1216-1224.
17. Akasaka T, Tsuji K, Kawahira H, et al. The role of mel-18, a mammalian Polycomb group gene, during IL-7-dependent proliferation of lymphocyte precursors. Immunity 1997;7:135-146.
18. Lessard J, Schumacher A, Thorsteinsdottir U, et al. Functional antagonism of the Polycomb-Group genes eed and Bmil in hemopoietic cell proliferation. Genes Dev 1999;13:2691-2703.
19. van der Lugt NM, Domen J, Linders K, et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev 1994;8:757-769.
20. Voncken JW, Roelen BA, Roefs M, et al. Rnf2 (Ring1b) deficiency causes gastrulation arrest and cell cycle inhibition. Proc Natl Acad Sci USA 2003;100:2468-2473.
21. Raaphorst FM, van Kemenade FJ, Fieret E, et al. Cutting edge: polycomb gene expression patterns reflect distinct B cell differentiation stages in human germinal centers. J Immunol 2000;164:1-4.
22. Raaphorst FM, Otte AP, van Kemenade FJ, et al. Distinct BMI-1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T cell differentiation. J Immunol 2001;166:5925-5934.
23. Park IK, Qian D, Kiel M, et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature 2003;423:302-305.
24. Kajiume T, Ninomiya Y, Ishihara H, et al. Polycomb group gene mel-18 modulates the self-renewal activity and cell cycle status of hematopoietic stem cells. Exp Hematol 2004;32:571-578.
25. Molofsky AV, Pardal R, Iwashita T, et al. Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature 2003;425:962-967.
26. Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003;423:255-260.
27. Simon JA, Tamkun JW. Programming off and on states in chromatin: mechanisms of Polycomb and trithorax group complexes. Curr Opin Genet Dev 2002;12:210-218.
28. Visser HP, Gunster MJ, Kluin-Nelemans HC, et al. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Br J Haematol 2001;112:950-958.
29. van Galen JC, Dukers DF, Giroth C, et al. Distinct expression patterns of polycomb oncoproteins and their binding partners during the germinal center reaction. Eur J Immunol 2004;34:1870-1881.
30. Kleer CG, Cao Q, Varambally S, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci USA 2003;100:11606-11611.
31. Rhodes DR, Sanda MG, Otte AP, et al. Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer. J Natl Cancer Inst 2003;95:661-668.
32. Varambally S, Dhanasekaran SM, Zhou M, et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 2002;419:624-629.
33. Haupt Y, Alexander WS, Barri G, et al. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in E mu-myc transgenic mice. Cell 1991;65:753-763.
34. Haupt Y, Bath ML, Harris AW, et al. bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis. Oncogene 1993;8:3161-3164.
35. Jacobs JJ, Scheijen B, Voncken JW, et al. Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev 1999;13:2678-2690.
36. Kohlhammer H, Schwaenen C, Wessendorf S, et al. Genomic DNA-chip hybridization in t(11;14)-positive mantle cell lymphomas shows a high frequency of aberrations and allows a refined characterization of consensus regions. Blood 2004;pp:795-801.
37. Bea S, Tort F, Pinyol M, et al. BMI-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas. Cancer Res 2001;61:2409-2412.
38. Dukers DF, van Galen JC, Giroth C, et al. Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines. Am J Pathol 2004;164:873-881.
39. Garcia JF, Camacho FI, Morente M, et al. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood 2003;101:681-689.
40. Raaphorst FM, van Kemenade FJ, Blokzijl T, et al. Coexpression of BMI-1 and EZH2 polycomb group genes in Reed-Sternberg cells of Hodgkin's disease. Am J Pathol 2000;157:709-715.
41. Schwering I, Brauninger A, Klein U, et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2003;101:1505-1512.
42. Sanchez-Beato M, Sanchez E, Garcia JF, et al. Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NFkappaB transcription factors. J Pathol 2004;204:528-537.
43. Leung C, Lingbeek M, Shakhova O, et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 2004;428:337-341.
44. Kim JH, Yoon SY, Kim CN, et al. The Bmi-1 oncoprotein is overexpressed in human colorectal cancer and correlates with the reduced p16INK4a/ p14ARF proteins. Cancer Lett 2004;203:217-224.
45. Vonlanthen S, Heighway J, Altermatt HJ, et al. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 2001;84:1372-1376.
46. van Kemenade FJ, Raaphorst FM, Blokzijl T, et al. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 2001;97:3896-3901.
47. Raaphorst FM, Vermeer M, Fieret E, et al. Site-specific expression of polycomb-group genes encoding the HPC-HPH/PRC1 complex in clinically defined primary nodal and cutaneous large B-cell lymphomas. Am J Pathol 2004;164:533-542.
48. Suzuki M, Mizutani-Koseki Y, Fujimura Y, et al. Involvement of the Polycomb-group gene Ring1B in the specification of the anterior-posterior axis in mice. Development 2002;129:4171-4183.
49. Paternoster SF, Brockman SR, McClure RF, et al. A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization. Am J Pathol 2002;160:1967-1972.
50. Palacios J, Honrado E, Osorio A, et al. Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. Clin Cancer Res 2003;9:3606-3614.
51. Matsuo F, Yano K, Saito H, et al. Mutation analysis of the mel-18 gene that shows decreased expression in human breast cancer cell lines. Breast Cancer 2002;9:33-38.
52. Gunster MJ, Raaphorst FM, Hamer KM, et al. Differential expression of human Polycomb group proteins in various tissues and cell types. J Cell Biochem 2001;81:129-143.
53. Lund AH, van Lohuizen M. Epigenetics and cancer. Genes Dev 2004;18:2315-2335.
54. Valk-Lingbeek ME, Bruggeman SW, van Lohuizen M. Stem cells and cancer; the polycomb connection. Cell 2004;118:409-418.
55. Jacobs JJ, Kieboom K, Marino S, et al. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 1999;397:164-168.
56. Atsuta T, Fujimura S, Moriya H, et al. Production of monoclonal antibodies against mammalian Ring1B proteins. Hybridoma 2001;20:43-46.